This website uses cookies.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Feature story

When Dinner Becomes an Expert Roundtable

Dr Ruben Mesa dines with two hematologists-oncologists to discuss the latest in myelofibrosis

Feature story

What's on Dr V's Mind Today?

He’s a global leader in myeloproliferative neoplasms. Now hear Dr V’s thoughts on MPN history, progress, hope, and the future.

Feature story

Myelofibrosis Research Takes Center Stage

Dr Savona explores how MF science mirrors music

Myelofibrosis education by leading researchers, doctors, and patients.

Explore stories, videos, and articles about MF symptoms, diagnosis, medical research, and hope.

subject
SPECIALISt
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Story

Get the Story Behind the Doctors' Dinner

Dr Mesa
Transfusions
Thrombocytopenia
Co-Treatment
San Antonio hosted a special dinner of MF experts who talked treatment, patients, and hope
VIEW ARTICLEView Story
Story

What's on Dr V's Mind Today?

Dr Verstovsek
Thrombocytopenia
He’s a global leader in myeloproliferative neoplasms. Now hear Dr V’s thoughts on MPN history, progress, hope, and the future.
VIEW ARTICLEView Story
Story

How Spleen Size Affects Overall Health

Dr Verstovsek
Splenomegaly
Dr Verstovsek explains why a small spleen is so important for patients
VIEW ARTICLEView Story
Video

Guarding Against Thrombocytopenia

Dr Verstovsek
Thrombocytopenia
Why cytopenic MF patients and their doctors must always monitor platelet count
VIEW ARTICLEView Story
Video

Myelofibrosis Medications are Real (and Growing)

Dr Verstovsek
Co-Treatment
Once only wishful thinking, newly-created MF medications provide hope and options for patients
VIEW ARTICLEView Story
Story

Partnering with Local Hematologists-Oncologists

Dr Verstovsek
Co-Treatment
Dr Verstovsek calls local hematologist-oncologists heroes, as he explains why collaborating with them is so important
VIEW ARTICLEView Story
Video

Cytopenic Patients and the Importance of Dosing

Dr Verstovsek
Latest Research
How dosing affects MF patients dealing with splenomegaly, enlarged liver, and quality of life
VIEW ARTICLEView Story
Story

Transplant Candidates Benefit from New Drugs

Dr Verstovsek
Latest Research
Patients now have drug options, like JAK inhibitors, to prepare them for hematopoietic stem cell transplant
VIEW ARTICLEView Story
Video

One-on-One: Dr Savona and His Patient, Cindy

Dr Savona
Patients’ Perspectives
Cindy’s MF journey, from diagnosis to transplant
VIEW ARTICLEView Story
Video

Conducting Myelofibrosis Research in Music City

Dr Savona
Mutations & Pathways
Latest Research
A handful of mutations, like a dozen notes in music, creates many different possibilities in myeloid disease
VIEW ARTICLEView Story
Story

12 Notes of Myelofibrosis

Dr Savona
Mutations & Pathways
Latest Research
Dr Savona sees a bright future for myelofibrosis research
VIEW ARTICLEView Story
Article

Navigating SVR Cytopenic MF Patients

No items found.
Reducing spleen size without exacerbating cytopenias has been a critical need
VIEW ARTICLEView Story
Video

The Myelofibrosis Exam Table Drawing

Kathryn Johnson
No items found.
Kathryn Johnson, DNP uses exam table paper to communicate to patients what is going on with their MF and their treatment
VIEW ARTICLEView Story
Story

HCP Insight to Help Plan Myelofibrosis Care

Kathryn Johnson
Symptoms of MF
Inflammation
Kathryn Johnson, DNP explains how patient conversations reveal clues that guide treatment
VIEW ARTICLEView Story
Article

Inflammation in MF: The Chicken or the Egg?

Symptoms of MF
Inflammation
Experts look at inflammation as a potential cause of myelofibrosis
VIEW ARTICLEView Story
Video

One-on-One: Dr Angela Fleischman and Her Patient, Bradley

Dr Fleischman
Inflammation
Mutations & Pathways
Patients’ Perspectives
Splenomegaly
Cytopenia
Real talk about symptoms, diagnosis, inflammation, blood cell counts, spleen size, and more
VIEW ARTICLEView Story
Story

Where is Inflammation Hiding in MF

Dr Fleischman
Mutations & Pathways
Symptoms of MF
Inflammation
Dr Fleischman takes us below the surface of symptoms to locate inflammation
VIEW ARTICLEView Story
Video

An MF Doctor Shares Connection with His Patients

Dr Scott
Latest Research
Patients’ Perspectives
Bart Scott, MD explains how surviving cancer empowers him to treat myelofibrosis patients
VIEW ARTICLEView Story
Story

Doctors Collaborating to Treat Myelofibrosis

Dr Scott
Co-Treatment
Latest Research
Together with hematologists-oncologists worldwide, Dr Scott supports comprehensive care for 300 MF patients annually
VIEW ARTICLEView Story
Video

Myelofibrosis Overview: Challenges Now and Future Hope

Dr Gerds
Mutations & Pathways
Splenomegaly
Symptoms of MF
Anemia
Thrombocytopenia
Aaron Gerds, MD explains his 5 big questions in MF
VIEW ARTICLEView Story
Story

Exploring the Biggest Questions in Myelofibrosis

Dr Gerds
Splenomegaly
Cytopenia
Anemia
Thrombocytopenia
Inflammation
Aaron Gerds, MD reveals why he never stops searching for better answers for people living with MF
VIEW ARTICLEView Story
Video

One-on-One: Dr Mascarenhas and His Patient, Gail

Dr Mascarenhas
Cytopenia
Patients’ Perspectives
Transfusions
Doctor and patient discuss what myelofibrosis patients can expect
VIEW ARTICLEView Story
Video

Dr Mascarenhas Looks at the Future of Myelofibrosis

Dr Mascarenhas
Mutations & Pathways
Cytopenia
Patients’ Perspectives
Latest Research
A preview of where MF breakthroughs can happen as research grows
VIEW ARTICLEView Story
Story

What’s Next in Myelofibrosis

Dr Mascarenhas
Cytopenic MF
Mutations & Pathways
John Mascarenhas, MD shares his latest insights: potential drivers, pathways, and possible solutions
VIEW ARTICLEView Story
This website uses cookies.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.